DE69324509D1 - CENP-B peptid - Google Patents

CENP-B peptid

Info

Publication number
DE69324509D1
DE69324509D1 DE69324509T DE69324509T DE69324509D1 DE 69324509 D1 DE69324509 D1 DE 69324509D1 DE 69324509 T DE69324509 T DE 69324509T DE 69324509 T DE69324509 T DE 69324509T DE 69324509 D1 DE69324509 D1 DE 69324509D1
Authority
DE
Germany
Prior art keywords
peptide
detection
cenp
anticentromere
autoantibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69324509T
Other languages
English (en)
Other versions
DE69324509T2 (de
Inventor
Ronald Verheyen
Venrooy Waltherus Jacobus Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE69324509D1 publication Critical patent/DE69324509D1/de
Publication of DE69324509T2 publication Critical patent/DE69324509T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Lubricants (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69324509T 1992-01-13 1993-01-12 CENP-B peptid Expired - Lifetime DE69324509T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92200065 1992-01-13

Publications (2)

Publication Number Publication Date
DE69324509D1 true DE69324509D1 (de) 1999-05-27
DE69324509T2 DE69324509T2 (de) 1999-10-07

Family

ID=8210361

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69324509T Expired - Lifetime DE69324509T2 (de) 1992-01-13 1993-01-12 CENP-B peptid

Country Status (12)

Country Link
EP (1) EP0552829B1 (de)
JP (1) JPH05310790A (de)
KR (1) KR100296198B1 (de)
AT (1) ATE179183T1 (de)
AU (1) AU664063B2 (de)
CA (1) CA2087143A1 (de)
DE (1) DE69324509T2 (de)
DK (1) DK0552829T3 (de)
ES (1) ES2132171T3 (de)
FI (1) FI109704B (de)
GR (1) GR3030727T3 (de)
ZA (1) ZA93174B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6900012B1 (en) 1997-06-03 2005-05-31 The University Of Chicago Plant artificial chromosome compositions and methods
US7227057B2 (en) 1997-06-03 2007-06-05 Chromatin, Inc. Plant centromere compositions
US7235716B2 (en) 1997-06-03 2007-06-26 Chromatin, Inc. Plant centromere compositions
US7119250B2 (en) 1997-06-03 2006-10-10 The University Of Chicago Plant centromere compositions
US7193128B2 (en) 1997-06-03 2007-03-20 Chromatin, Inc. Methods for generating or increasing revenues from crops
US6177254B1 (en) * 1998-12-15 2001-01-23 Jerome Bernard Rattner Nucleolus autoantigenic marker for systemic lupus erthyematosus
US7989202B1 (en) 1999-03-18 2011-08-02 The University Of Chicago Plant centromere compositions
US8729341B2 (en) 2004-02-23 2014-05-20 University Of Chicago Plants modified with mini-chromosomes
KR100693042B1 (ko) * 2004-11-10 2007-03-12 삼성전자주식회사 무선 전원 공급 장치 및 그 방법
CA2621874C (en) 2005-09-08 2014-12-16 Chromatin Inc. Plants modified with mini-chromosomes
US8614089B2 (en) 2007-03-15 2013-12-24 Chromatin, Inc. Centromere sequences and minichromosomes
CA2767724A1 (en) 2009-07-23 2011-01-27 Chromatin, Inc. Sorghum centromere sequences and minichromosomes
DE102009039705A1 (de) 2009-08-31 2011-04-07 Dr. Fooke Laboratorien Gmbh Peptide des CENP-A und ihre Verwendung
ES2395100B2 (es) * 2011-07-11 2013-09-13 Univ Cadiz Metodo de obtencion de datos utiles para el diagnostico diferencial de la esclerodermia.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091303A (en) * 1989-10-27 1992-02-25 The General Hospital Corporation Diagnosis of wegener's granulomatosis

Also Published As

Publication number Publication date
ES2132171T3 (es) 1999-08-16
CA2087143A1 (en) 1993-07-14
ZA93174B (en) 1993-08-13
FI930106A (fi) 1993-07-14
FI930106A0 (fi) 1993-01-12
GR3030727T3 (en) 1999-11-30
AU664063B2 (en) 1995-11-02
KR100296198B1 (ko) 2001-10-22
EP0552829B1 (de) 1999-04-21
FI109704B (fi) 2002-09-30
KR930016439A (ko) 1993-08-26
JPH05310790A (ja) 1993-11-22
DE69324509T2 (de) 1999-10-07
AU3114993A (en) 1993-07-15
ATE179183T1 (de) 1999-05-15
EP0552829A1 (de) 1993-07-28
DK0552829T3 (da) 1999-10-25

Similar Documents

Publication Publication Date Title
DE69324509D1 (de) CENP-B peptid
DE69332988D1 (de) Reagenzien zum Nachweis und zur Quantifizierung von Thyroxin in flüssigen Proben
DK104093D0 (da) Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
NO175639C (no) Peptid, antistoff oppnådd ved hjelp av peptidet, en fremgangsmåte for immunologisk bestemmelse av intakt prokollagen peptid (type III) og anvendelse av peptidet
DE69312185D1 (de) Chromatographischer Sandwichtest zur Bestimmung von spezifischen Antikörpern und Vorrichtung hierfür
FI98705B (fi) Monoklonaalinen vasta-aine intaktin prokollageenipeptidin (tyyppi III) ja prokollageenin (tyyppi III) selektiiviseksi immunologiseksi määrittämiseksi ruumiinnesteistä
ATE153770T1 (de) Künstliche standard- und kontrollseren zur verwendung in verfahren zur bestimmung von antikörpern
CA2120342A1 (en) Epstein-barr virus peptides and antibodies against these peptides
NO881905L (no) Monoklonalt antistoff til selektiv immunologisk bestemmelse av intakt prokollagen peptid (type iii) og prokollagen (type iii) i kroppsvaesker.
FI914673A0 (fi) Peptider, som reagerar immunokemiskt med antikroppar mot hepatitis icke-a, icke-b-virus.
ITMI930477A0 (it) Saggio per la determinazione di un antigene/anticorpo in un campione di prova e corredo per l'attuazione del saggio
WO1993011158A3 (en) Non-a, non-b peptides
ATE112782T1 (de) Mit antikörper gegen hepatitis non-a, non-b-virus immunochemische reaktive peptide.
EP0096520A3 (de) Antigennachweis:Rheumatoide Arthritis
WO1994002507A3 (en) Methods for detecting pre-clinical iddm
FI893333A0 (fi) Menetelmä ja reagenssi vasta-aineiden määrittämiseksi
SE7904276L (sv) Renat cancerassocierat protein
DK316089A (da) Fremgangsmaade til paavisning af antistoffer eller antigener i et testfluidum samt proevesaet til anvendelse ved fremgangsmaaden
AU2370692A (en) Method to detect antibodies against hepatitis c virus and kits for the use thereof
DE58902996D1 (de) Verfahren zum nachweis von antikoerpern gegen erythrozytenspezifische antigene.
DK305084A (da) Partikel samt fremgangsmaade til paavisning af antigener og/eller antistoffer under anvendelse af partiklen
IE882302L (en) Antigen fractions for detecting antibodies indicative of a¹cardiovascular risk

Legal Events

Date Code Title Description
8364 No opposition during term of opposition